Quick answers
- What is Gocovri?
- Gocovri is a brand name of Amantadine, a prescription medicine. The FDA NDC Directory lists 4 Gocovri products in 2 strengths and forms.
- Who makes Gocovri?
- Supernus Pharms holds the FDA application for Gocovri (NDA208944, approved August 24, 2017). 1 other company (repackagers or distributors) also list Gocovri products.
- Is there a generic or store brand of Gocovri?
- Other products of Amantadine are listed with the FDA, but none in exactly the same strength and form as a Gocovri product.
- Has Gocovri been recalled?
- No recall linked to Gocovri products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Gocovri is
Each Gocovri product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Amantadine · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| amantadine 137 mg capsule, coated pellets (oral) | Gocovri | None listed | — |
| amantadine 68.5 mg capsule, coated pellets (oral) | Gocovri | None listed | — |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Amantadine →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA208944 | Supernus Pharms | August 24, 2017 | 4 |
Companies that list Gocovri
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Gocovri products.
- Adamas Pharma, LLC2 products
- Supernus Pharmaceuticals, Inc.2 products
Recalls
No recall linked to Gocovri products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.